Drugs / Aeroderm
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00676884 | Feb → Jul 2006 | atopic eczema | Aerovance, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aeroderm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00676884 ↗ |
| Known as | BAY 16-9996 | “Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996)” NCT00676884 ↗ |
| Route | Subcutaneous | “30 mgs s.c. b.i.d.” NCT00676884 ↗ |